-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Explore the new world---standardized curriculum "Prostate Cancer Standardized Diagnosis and Treatment College" project is sponsored by the Beijing Medical Award Foundation, guided by the Chinese Anti-Cancer Association Urology and Andrology Reproductive Tumor Committee, and Yimaitong fully supports it.
Among them, the "Prostate Cancer Standardized Diagnosis and Treatment Course" aims to promote and promote the knowledge of standardized diagnosis and treatment of prostate cancer, and improve the academic level and professional skills in the field of prostate cancer across the country.
The first phase of "Prostate Cancer Standardized Diagnosis and Treatment Course" Phase 1 is the "Screening and Early Diagnosis of Prostate Cancer" by Professor Zeng Yu from Liaoning Cancer Hospital: Click to watch the highlights video! Highlight video Since the 21st century, the incidence of prostate cancer has been increasing, and the death/incidence ratio of prostate cancer in China has remained high, which has seriously threatened the lives and health of men.
Prostate cancer screening and early diagnosis are conducive to early clinical intervention and treatment, so that patients can obtain better survival results.
So, what is the screening population, screening interval and screening method for prostate cancer? How to make the pathological diagnosis and staging of prostate cancer? What does the CSCO prostate cancer diagnosis and treatment guidelines emphasize? This issue of "Screening and Early Diagnosis of Prostate Cancer" will discuss and share these topics in detail to help clinicians familiarize and master the methods of screening and early diagnosis of prostate cancer, and improve the clinical benefits of patients.
Watch the full video please
Among them, the "Prostate Cancer Standardized Diagnosis and Treatment Course" aims to promote and promote the knowledge of standardized diagnosis and treatment of prostate cancer, and improve the academic level and professional skills in the field of prostate cancer across the country.
The first phase of "Prostate Cancer Standardized Diagnosis and Treatment Course" Phase 1 is the "Screening and Early Diagnosis of Prostate Cancer" by Professor Zeng Yu from Liaoning Cancer Hospital: Click to watch the highlights video! Highlight video Since the 21st century, the incidence of prostate cancer has been increasing, and the death/incidence ratio of prostate cancer in China has remained high, which has seriously threatened the lives and health of men.
Prostate cancer screening and early diagnosis are conducive to early clinical intervention and treatment, so that patients can obtain better survival results.
So, what is the screening population, screening interval and screening method for prostate cancer? How to make the pathological diagnosis and staging of prostate cancer? What does the CSCO prostate cancer diagnosis and treatment guidelines emphasize? This issue of "Screening and Early Diagnosis of Prostate Cancer" will discuss and share these topics in detail to help clinicians familiarize and master the methods of screening and early diagnosis of prostate cancer, and improve the clinical benefits of patients.
Watch the full video please
